×
Entrez Id:
9670
Gene Symbol:
IPO13
IPO13
0.010
AlteredExpression
disease
BEFREE
IPO13 activity was significantly increased in the basal layer of the epithelium of the pterygium .
23559854
2013
×
Entrez Id:
7015
Gene Symbol:
TERT
TERT
0.010
AlteredExpression
disease
BEFREE
Telomerase reverse transcriptase was expressed, and p53 and p16 levels were reduced in immortalized pterygium fibroblast cells.
24012806
2013
×
Entrez Id:
6387
Gene Symbol:
CXCL12
CXCL12
0.020
AlteredExpression
disease
BEFREE
Stromal cell-derived factor 1 levels in cultured pterygial fibroblasts correlated positively with the severity of pterygia .
24114538
2013
×
Entrez Id:
6279
Gene Symbol:
S100A8
S100A8
0.020
Biomarker
disease
BEFREE
S100A8 /9 may be an upstream trigger for inflammation and other disease pathways in pterygium .
24825356
2014
×
Entrez Id:
56955
Gene Symbol:
MEPE
MEPE
0.010
Biomarker
disease
BEFREE
Of 45 pterygia samples with acceptable DNA quality, 29 (64.4%) were positive for HPV DNA, whereas all the normal conjunctiva swabs were HPV negative.
25043991
2014
×
Entrez Id:
7124
Gene Symbol:
TNF
TNF
0.030
AlteredExpression
disease
BEFREE
TNF-α upregulates HIF-1α expression in pterygium fibroblasts and enhances their susceptibility to VEGF independent of hypoxia.
28803935
2017
×
Entrez Id:
3091
Gene Symbol:
HIF1A
HIF1A
0.020
AlteredExpression
disease
BEFREE
HIF-1α and VEGF expression were detected in 6/6 surgically excised pterygia and localized to CjECs.
28873177
2017
×
Entrez Id:
3490
Gene Symbol:
IGFBP7
IGFBP7
0.010
AlteredExpression
disease
BEFREE
IGFBP-7 expression was determined in normal (n=83) and conjunctivalized (n=52) mouse corneas with experimentally-induced LSCD, and in cadaveric normal human corneas (n=7) and human pterygia (n=15); a disease characterized by the invasion of a conjunctivalized, fibrovascular pannus.
31125784
2019
×
Entrez Id:
8482
Gene Symbol:
SEMA7A
SEMA7A
0.010
AlteredExpression
disease
BEFREE
Semaphorin 7a was highly expressed in the primary pterygium and recurrent pterygium samples than that of the normal conjunctival tissue.
31236342
2019
×
Entrez Id:
407025
Gene Symbol:
MIR29B2
MIR29B2
0.010
Biomarker
disease
BEFREE
MiR-29b -3p and collagen family (COL4A1 and COL3A1) might be new treatment target in pterygium .
31341891
2019
×
Entrez Id:
407024
Gene Symbol:
MIR29B1
MIR29B1
0.010
Biomarker
disease
BEFREE
MiR-29b -3p and collagen family (COL4A1 and COL3A1) might be new treatment target in pterygium .
31341891
2019
×
Entrez Id:
6387
Gene Symbol:
CXCL12
CXCL12
0.020
Biomarker
disease
BEFREE
SDF-1 /CXCR4 signaling may play a vital role in pterygium and shorter axial length.
31714404
2020
×
Entrez Id:
4312
Gene Symbol:
MMP1
MMP1
0.030
Biomarker
disease
BEFREE
A dose- and time-dependent increase in MMP-1 was observed when pterygium epithelial cells were exposed to UVB with no significant modulation of inhibitor activity.
14578390
2003
×
Entrez Id:
6707
Gene Symbol:
SPRR3
SPRR3
0.010
Biomarker
disease
BEFREE
A gene signature consisting of 11 DEGs were found to be shared by pterygium and MGD (SPRR3 , SERPINB13, NMU, KRT10, IL37, KRT6B, PI3, S100A2, MAL, AURKA, and RGCC), and bioinformatics analyses showed that these overlapped DEGs were significantly enriched in pathways related to keratinization, cell-cycle regulation, and formation of the cornified envelope.
31373692
2019
×
Entrez Id:
54101
Gene Symbol:
RIPK4
RIPK4
0.030
Biomarker
disease
BEFREE
A novel RIPK4 -IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.
25430793
2015
×
Entrez Id:
3664
Gene Symbol:
IRF6
IRF6
0.090
Biomarker
disease
BEFREE
A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.
25430793
2015
×
Entrez Id:
7442
Gene Symbol:
TRPV1
TRPV1
0.020
AlteredExpression
disease
BEFREE
A significant correlation between the TRPV1 and TRPV3 expression levels (P<0.001) was detected independently of pterygium recurrence.
28849159
2017
×
Entrez Id:
162514
Gene Symbol:
TRPV3
TRPV3
0.010
AlteredExpression
disease
BEFREE
A significant correlation between the TRPV1 and TRPV3 expression levels (P<0.001) was detected independently of pterygium recurrence.
28849159
2017
×
Entrez Id:
1636
Gene Symbol:
ACE
ACE
0.010
Biomarker
disease
BEFREE
A statistically significant difference was found between the pterygium and control groups for the ACE I /D polymorphism (p<0.001).
25341451
2014
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.100
AlteredExpression
disease
BEFREE
Abnormal p53 expression in the epithelium of primary and recurrent pterygium specimens suggests that pterygium is a growth disorder rather than a degeneration.
9063255
1997
×
Entrez Id:
2475
Gene Symbol:
MTOR
MTOR
0.010
AlteredExpression
disease
BEFREE
Additionally, mTOR expression was significantly correlated with α-SMA expression (ρ = 0.269, p = 0.031) in pterygium .
28623647
2017
×
Entrez Id:
6606
Gene Symbol:
SMN1
SMN1
0.030
AlteredExpression
disease
BEFREE
Additionally, mTOR expression was significantly correlated with α-SMA expression (ρ = 0.269, p = 0.031) in pterygium .
28623647
2017
×
Entrez Id:
6607
Gene Symbol:
SMN2
SMN2
0.030
AlteredExpression
disease
BEFREE
Additionally, mTOR expression was significantly correlated with α-SMA expression (ρ = 0.269, p = 0.031) in pterygium .
28623647
2017
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.100
AlteredExpression
disease
BEFREE
After p53 protein was found to be abnormally expressed in the epithelium, researchers suggested that a pterygium may be a tumor, but additional evidence is required to support this hypothesis.
17149367
2006
×
Entrez Id:
218
Gene Symbol:
ALDH3A1
ALDH3A1
0.010
AlteredExpression
disease
BEFREE
Among these genes, we chose three proteins, aldehyde dehydrogenase, dimeric NADP-preferring (ALDH3A1 ), protein disulfide-isomerase A3 (PDIA3), and peroxiredoxin-2 (PRDX2), that were significantly upregulated in pterygium and further increased in recurrent pterygium.
25221425
2014